GAITHERSBURG, Md., Jan. 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...

(RTTNews) - Novavax Inc. (NVAX) said that Australia's Therapeutic Goods Administration or TGA has granted approval for provisional registration of NVX-CoV2373, Novavax' COVID-19 vaccine (adjuvanted), ...

Novavax Inc NVAX said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The Maryland-based biotechnology company said that Australia’s ...

CANBERRA, AustraliaCANBERRA, Australia — Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia. The country has ordered 51 million doses of the U.S.

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have saved more than 1.4 million lives in the World Health Organization's (WHO) ...

PERTH, Australia – In preparation for easing COVID-19 restrictions and opening its international borders, Australia has added a new vaccine and two new oral antiviral therapies to its arsenal to fight ...

FILE - In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London. The Novavax ...

Novavax Inc. said Friday it has filed for provisional approval of its COVID-19 vaccine in Australia. "The company's application to the TGA marks the first complete application for provisional approval ...